quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:45:00·330d
NEWSRelease
TRxADE HEALTH Inc. logo
Wellgistics Health Inc. logo

Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value

MEDS· TRxADE HEALTH Inc.WGRX· Wellgistics Health Inc.
Health Care
Original source

Companies

  • MEDS
    TRxADE HEALTH Inc.
    Health Care
  • WGRX
    Wellgistics Health Inc.
    Health Care

Recent analyst ratings

  • Dec 9MEDSUpdateEF Hutton$4.50

Related

  • INSIDER5h
    Chief Executive Officer Patel Prashant was granted 5,000,000 shares, increasing direct ownership by 121% to 9,118,247 units (SEC Form 4)
  • INSIDER5h
    Director Ajjarapu Surendra K was granted 5,000,000 shares, increasing direct ownership by 173% to 7,882,247 units (SEC Form 4)
  • SEC2d
    Amendment: Wellgistics Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC6d
    Wellgistics Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC8d
    SEC Form S-3 filed by Wellgistics Health Inc.
  • NEWS9d
    Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
  • INSIDER13d
    SEC Form 3 filed by new insider Herman Gary L
  • INSIDER14d
    SEC Form 3 filed by new insider Sherb Eric Michael
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022